2-Oxazolidinone → 3-{5-[4-(2,4-Dimethylphenyl)piperazine-1-carbonyl]pyridin-2-yl}oxazolidin-2-one

HRID 1804170Notes

Reaction equation

HRID 1804170 reaction equation
Br[C:2]1[N:7]=[CH:6][C:5]([C:8]([N:10]2[CH2:15][CH2:14][N:13]([C:16]3[CH:21]=[CH:20][C:19]([CH3:22])=[CH:18][C:17]=3[CH3:23])[CH2:12][CH2:11]2)=[O:9])=[CH:4][CH:3]=1.[O:24]1[CH2:28][CH2:27][NH:26][C:25]1=[O:29]>>[CH3:23][C:17]1[CH:18]=[C:19]([CH3:22])[CH:20]=[CH:21][C:16]=1[N:13]1[CH2:14][CH2:15][N:10]([C:8]([C:5]2[CH:4]=[CH:3][C:2]([N:26]3[CH2:27][CH2:28][O:24][C:25]3=[O:29])=[N:7][CH:6]=2)=[O:9])[CH2:11][CH2:12]1

Participants

3

Procedure

By reaction and treatment in the same manner as in Example 1 and using (6-bromopyridin-3-yl)[4-(2,4-dimethylphenyl)piperazin-1-yl]methanone (749 mg) described in Preparation Example 20 and oxazolidin-2-one (174 mg), the title compound (473 mg) was obtained.

Workup

  1. customBy reaction and treatment in the same manner as in Example 1

Sources & evidence

ORD record
ord-f2f048de7f544d33bf4c905382a90c5d
Source dataset
uspto-grants-2013_01
Patent number
US08354401B2

Reaction notes

Loading…